Why the study?
Existing vaccines cannot provide complete protection against feline calicivirus due to substantial genetic variability, prompting research on antiviral drugs.
Does copper chloride have an antiviral effect against feline calicivirus in vitro?
Does copper chloride have an antiviral effect against feline calicivirus in vitro?
Copper chloride demonstrates dose-dependent antiviral activity against feline calicivirus in vitro and acts synergistically with ribavirin.
Answers are grounded in this paper and cite their sources.
Should not yet change FCV management in cats; hypothesis-generating for copper-based antivirals in veterinary virology.
Background Feline calicivirus (FCV) is a common and highly prevalent pathogen causing upper respiratory diseases in kittens and felines in recent years. Due to the substantial genetic variability of the viral genes, existing vaccines cannot provide complete protection. Therefore, research on FCV antiviral drugs has received much attention. Results In this study, we found that copper chloride had dose-dependent antiviral effects on FCV in F81 cells. We also found that the combination of copper chloride and ribavirin had a synergistic protective effect against FCV in F81 cells. In contrast, the combination of copper chloride and horse anti-FCV immunoglobulin F (ab’) 2 showed an antagonistic effect, likely because copper chloride has an effect on F (ab’) 2 immunoglobulin; however, further research is needed to clarify this supposition. Conclusions In summary, we found that copper chloride had low cytotoxicity and significant antiviral effects on FCV in F81 cells, providing a new drug candidate for the prevention and treatment of FCV infection.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: